SNANF (Sona Nanotech) PS Ratio: (As of Jul. 07, 2026)


SNANF Sona Nanotech Inc SNANF
26 GF Score
Price $0.24
! 1 Warning Sign
View Full Analysis

What is Sona Nanotech PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sona Nanotech's share price is $0.23522. Sona Nanotech's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was $0.00. Hence, Sona Nanotech's PS Ratio for today is .

The historical rank and industry rank for Sona Nanotech's PS Ratio or its related term are showing as below:

SNANF's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 9.64
* Ranked among companies with meaningful PS Ratio only.

Sona Nanotech's Revenue per Sharefor the three months ended in Apr. 2026 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was $0.00.

Back to Basics: PS Ratio


Sona Nanotech  (OTCPK:SNANF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Sona Nanotech PS Ratio Related Terms


Sona Nanotech PS Ratio Historical Data

* Premium members only.

The historical data trend for Sona Nanotech's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sona Nanotech PS Ratio Chart

Sona Nanotech Annual Data
Trend Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sona Nanotech Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SNANF vs TMO, DHR, IDXX: PS Ratio Comparison

For the Biotechnology subindustry, Sona Nanotech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sona Nanotech's PS Ratio distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's PS Ratio falls into.


SNANF
26GF Score
Sona Nanotech Inc SNANF
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sona Nanotech PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Sona Nanotech's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.23522/0
=

Sona Nanotech's Share Price of today is $0.23522.
Sona Nanotech's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Sona Nanotech Business Description

Other Exchanges SONA:Canada
Address 1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc is involved in the nanotechnology life sciences industry. It has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles and is engaged in the research and development of its proprietary technology for use in biomedical applications and multiplex diagnostic testing platforms. The company is using its gold nano rods manufacturing technology to develop new products and methods for cancer treatment, including a Targeted Hyperthermia Therapy (THT). Additionally, it has filed patent applications in the U.S. regarding a gold nanorod conjugation concept for targeted drug delivery, combination therapies for treating cancer, and for an endoscope with an optical fibre and thermal sensor for photothermal therapy.
26GF Score

Get the complete analysis for SNANF

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.24
Price